The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection

Nature Medicine

Volumn 2, Issue 11, 1996, Pages 1244-1247

  Cocchi, Fiorenza ^a   DeVico, Anthony L ^a   Garzino Demo, Alfredo ^a   Cara, Andrea ^c   Gallo, Robert C ^a   Lusso, Paolo ^a,b  

^a INSTITUTE OF HUMAN VIROLOGY   (United States)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CHEMOKINE; GLYCOPROTEIN; GLYCOPROTEIN GP 120;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN DOMAIN;

AMINO ACID SEQUENCE; CELL LINE; CHEMOKINES; DNA, VIRAL; HIV CORE PROTEIN P24; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; MACROPHAGE INFLAMMATORY PROTEIN-1; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PERTUSSIS TOXIN; RANTES; RECOMBINANT FUSION PROTEINS; VIRULENCE FACTORS, BORDETELLA;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0029955497     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1196-1244     Document Type: Article

References (34)

1. Walker, C.M., Moody, D., Stites, O.P. & Levy, J.A. CD8- lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234, 1563-1566 (1986).
2. + T lymphocytes suppresses HIV replication. Immunology 66, 628-630 (1989).
3. + T cells: Evidence for a soluble inhibitor. J. Immunol. 144, 2961-2966 (1990).
4. + cell anti-HIV activity correlates with the clinical state of the infected individual. J. Clin. Invest. 87, 1462-1466 (1991).
5. + T cells correlates with CD4 counts and clinical stage of disease. Clin. Exp. Immunol. 97, 68-75 (1994).
6. + T cells. Science 270, 1811-1815 (1995).
7. Loetscher, M., et al. Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes. J. Biol. Chem. 269, 232-237 (1994).
8. Samson, M., Labbé, O., Molereau, C., Vassart, G. & Parmentier, M. Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry 35, 3362-3367 (1996).
9. Feng, Y., Broder, C.C., Kennedy, P.E. & Berger, E.A. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872-877 (1996).
10. Deng, HK. et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381, 661-666 (1996).
11. + cells is mediated by the chemokine receptor C-C CKR-5. Nature 381, 667-673 (1996).
12. Alkhatib, G. et al. CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272, 1955-1958 (1996).
13. Gartner, S. et al. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 233, 215-219 (1986).
14. Popovic, M., Sarngadharan, M.G., Read, E. & Gallo, R.C. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224, 497-500 (1984).
15. + T-cell clone (PM1): Failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1. J. Virol. 69, 3712-3720 (1995).
16. Murphy, P.M. The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol. 12, 593-633 (1994).
17. Simon, M.I., Strathmann, M.P. & Gautan, N. Diversity of G proteins in signal transduction. Science 252, 802-807 (1991).
18. Palker, T.J. et al. Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides. Proc. Natl. Acad. Sci. USA 85, 1932-1936 (1988).
19. Rusche, J.R. et al. Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. Proc. Natl. Acad. Sci. USA 85, 3198-3202 (1988).
20. Javaherian, K.A. et al. Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. Proc. Natl. Acad. Sci. USA 86, 6768-6772 (1989).
21. Freed, E.O., Myers, D.J. & Risser, R. Identification of the principal neutralizing determinant of human immunodeficiency virus type 1 as a fusion domain. J. Virol. 65, 190-194 (1991).
22. Shioda, T., Levy, J.A. & Cheng-Meyer, C. Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature 349, 167-169 (1991).
23. Takeuchi, Y., Akutsu, M., Murayama, K., Shimizu, N. & Hoshino, H. Host range mutant of human immunodeficiency virus type 1: Modification of cell tropism by a single point mutation at the neutralization epitope in the env gene. J. Virol. 65, 1710-1718 (1991).
24. Chesebro, B., Wehrly, K., Nishio, J. & Perryman, S. Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: Definition of critical amino acids involved in cell tropism. J. Virol. 66, 6547-6554 (1992).
25. Hwang, S.S., Boyle, T.J., Lyerly, H.K. & Cullen, B.R. Identification of envelope V3 loop as the major determinant of CD4 neutralization sensitivity of HIV-1. Science 257, 535-537 (1992).
26. Ivanoff, L.A. et al. V3 loop region of the HIV-1 gp120 envelope protein is essential for virus infectivity. Virology 187, 423-432 (1992).
27. Paxton, W.A. et al. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remained uninfected despite multiple high-risk sexual exposure. Nature Med. 2, 412-417 (1996).
28. Bacon, K.A., Premack, B.A., Gardner, P., Schall, T.J. Activation of dual T cell signaling pathways by the chemokine RANTES. Science 269, 1727-1730 (1995).
29. Koito, A., Harrowe, G., Levy, J.A. & Cheng-Mayer, C. Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 In infection of primary macrophages and soluble CD4 neutralization. J. Virol. 68, 2253-2259 (1994).
30. Willey, R.L. & Martin, M.A. Association of human immunodeficiency virus type 1 envelope glycoprotein with particles depends on interactions between the third variable and conserved regions of gp120. J. Virol. 67, 3639-3643 (1993).
31. Stamatatos, L., Werner, A. & Cheng-Mayer, C. Differential regulation of cellular tropism and sensitivity to soluble CD4 neutralization by the envelope gp120 of human immunodeficiency virus type 1. J. Virol. 68, 4973-4979 (1994).
32. Carrillo, A. & Ratner, L. Human immunodeficiency virus type 1 tropism for T-lymphoid cell lines: role of the V3 loop and C4 envelope determinants. J. Virol. 70, 1301-1309 (1996).
33. Gao, W.-Y., Cara, A., Gallo, R.C. & Lori, F. Low levels of deoxynucleotides in peripheral blood lymphocytes: a strategy to inhibit human immunodeficiency virus replication. Proc. Natl. Acad. Sci. USA 90, 8925-8928 (1993).
34. Sambrook, J., Fritsch, E.F. & Maniatis, T. Molecular Cloning: A Laboratory Manual, edn. 2 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1989).